FindTrial
Sign In

A study to evaluate effect of consumption of food products on Blood Sugar in healthy human volunteers.

A study to evaluate effect of consumption of food products on Glycemic index in healthy human volunteers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087621
Enrollment
16
Registered
2025-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Product 1: NS-65: 32.6 g of the product will be mixed with 326 ml skimmed milk Intervention2: Product 2: SMC-66: 32.6 g of the product will be mixed with 326 ml skimmed milk Interventio

Sponsors

Amway Global Services India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy adults (based on medical history and screening tests) in the age group of 18 and 45 years male subjects 2.Fasting blood glucose levels less than 100mg per dL. 3.HOMA IR (Homeostasis Model Assessment of Insulin Resistance) less than 2.5 as per American Diabetes Association (ADA) 4.Glycosylated Hemoglobin (HbA1c) less than 5.6 as per American Diabetes Association (ADA 5.BMI should be between 18.5 to 25 kg per m2 6.Lipid profile (Total cholesterol) within normal range as applicable 7.Must be willing to give written informed consent and comply with the study procedures. 8.Subject s complete blood count parameters to be within clinically acceptable range by Investigator.

Exclusion criteria

Exclusion criteria: 1.Total cholesterol higher than normal range. 2.Subjects particularly on any special diet 3.Subjects suffering from any systemic disorders (diabetes mellitus, cardiovascular, renal, pulmonary, endocrine, or neurological disorders, ulcers, dermatologic disorders, autoimmune diseases) or severe food allergies; an active infectious disease (HBV, HCV, HIV) 4.current diagnosis or a history of relevant depressive episodes or of panic attacks, psychosis, bipolar or eating disorders 5.Patient having participated in any other clinical trial within one month prior to screening

Design outcomes

Primary

MeasureTime frame
To assess glycemic index using blood sugar levels measured at fixed intervals.Timepoint: To assess glycemic index using blood sugar levels measured at fixed intervals at 7 time points (-5, 15, 30, 45, 60, 90 and 120 min)—

Secondary

MeasureTime frame
- To assess change in hematological and biochemical parameters from baseline to end of the study. - Assessment adverse events during the study period.Timepoint: At baseline & end of the Study—

Countries

India

Contacts

Public ContactDr Sudha Raj

Amway Global Services India Pvt Ltd

Palaniyamma.Durairaj@Amway.com7022247227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026